I join Mark Longo of Options Insider, Mark Sebastian of Option Pit and Russell Rhoads of the Cboe to discuss the VIX and Bitcoin.
We look at a huge trade in the VIX and backtest the strategy. The backtest of the generalized parameters of the trade does not perform well.
ORATS most popular IV data point is our interpolated implied volatility reading. It is also...
Celgene (CELG) is to be bought by Bristol-Myers Squibb (BMY) at a 54% premium to the closing...
Still curious how we can help you?
1608 S. Ashland Ave. #98141
Chicago, IL 60608
36 Maplewood Ave.
Portsmouth, NH 03801